Physician profile
Haritha Alla
NPI 1487739835
$2,457.03
in general payments reported to CMS, 2019-2025
28 companies · $809 in 2025
The $809 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $357 · 2021: $175 · 2023: $393 · 2024: $494 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,696.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $382.78 | 2023-2025 | Arexvy, Nucala, Shingrix |
| Pfizer INC. | $317.58 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $220.45 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $208.09 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $186.32 | 2019-2024 | Farxiga |
| Abbott Laboratories | $146.28 | 2023 | Mitraclip |
| Regeneron Healthcare Solutions, INC. | $117.92 | 2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $106.10 | 2019-2025 | Eliquis |
| Astellas Pharma US INC | $99.95 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.78 | 2023-2025 | |
| Amarin Pharma, INC. | $78.82 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.07 | 2020-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $49.67 | 2021-2025 | Verquvo |
| Medtronic, INC. | $49.40 | 2025 | Symplicity G3 |
| Cardiva Medical, INC. | $44.67 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $42.64 | 2020-2024 | Nexletol |
| Edwards Lifesciences Corporation | $35.26 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sun Pharmaceutical Industries INC. | $23.47 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.86 | 2019 | |
| Xeris Pharmaceuticals, INC. | $22.42 | 2021 | |
| Lundbeck LLC | $21.56 | 2020 | |
| Scpharmaceuticals INC. | $18.78 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $18.59 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $18.35 | 2025 | Assure Wcd |
| W. L. Gore & Associates, INC. | $17.06 | 2020 | |
| Boston Scientific Corporation | $16.16 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.49 | 2024 | Lifevest |
| Janssen Scientific Affairs, LLC | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haritha Alla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.